Skip to main content
Hematology and Oncology
ALL Specialities
ALL Specialities
/
Hematology and Oncology
Blood & Cancer Podcast
CME
Diseases & Conditions
Nonmalignant Hematologic Disorders
Anemia
Bleeding Disorders
Thrombosis
Breast Cancer
CNS/Brain Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Renal Cell Carcinoma
Gynecologic Cancer
Head & Neck/Thyroid Cancers
Leukemia, Myelodysplasia, Transplantation
ALL
AML
Cellular Therapy
CLL
CML
Myelodysplastic Syndrome
Transplantation
Lung Cancer
Lymphoma & Plasma Cell Disorders
B Cell Lymphoma
Follicular Lymphoma
Hodgkin Lymphoma
Mantle Cell Lymphoma
Multiple Myeloma
Non-Hodgkin Lymphoma
T Cell Lymphomas
Melanoma
Nonmelanoma Skin Cancer
Sarcoma and GIST
COVID-19 Updates
Conference Coverage
Conference Coverage
Mammography screening at 75 may have value
Publish date:
April 9, 2013
AT THE AACR ANNUAL MEETING
Dr. Simon had no financial disclosures.
msullivan@frontlinemedcom.com
Pages
« first
1
2
Recommended Reading
End-of-life care gains increasing prominence
MDedge Hematology and Oncology
New geriatric assessments aid cancer treatment decisions
MDedge Hematology and Oncology
Lenalidomide branches out to lymphoma therapy
MDedge Hematology and Oncology
In Europe, melanoma is rising in men over 60
MDedge Hematology and Oncology
Survival higher with surveillance of small kidney tumors
MDedge Hematology and Oncology
End-of-life hypoactive delirium responds to antipsychotics
MDedge Hematology and Oncology
Escitalopram during cancer treatment reduces depression risk
MDedge Hematology and Oncology
New palliative care guidelines stress certification, diversity
MDedge Hematology and Oncology
Nurse-led delirium screen validated in hospitalized elderly
MDedge Hematology and Oncology
YouTube poor source of palliative information
MDedge Hematology and Oncology
Breast Cancer
All Specialties
